Pfizer Fined, Colorectal Cancer Screening Disparities

Pharmacia, acquired by Pfizer in 2003 was responsible in inflation of medicine prices according to a ruling by a Wisconsin jury. The meds were sold to the Medicaid program of the state. As a result Pfizer has been fine $9 mn in total. Out of this $2 mn is for consumer protection law violation and $7 mn is for monetary losses.

Additionally state medicare law had been violated 1.4 mn times by Pharmacia. Each violation can attract a penalty of between $100 to $15,000. Pfizer is likely to appeal the verdict.
There has been an increase in colorectal cancer screenings among Medicare beneficiaries. A new study says that white beneficiaries are screened more often. These are the findings of a new study. Data from the National Cancer Institute database was used for this study.

Meanwhile it seems that Medicare patients do not get powerful acute stroke drugs in most hospitals in the U.S. There is a great need for broader access of this drug.